BiotechTube
Aska Biotech

Aska Biotech

Göttingen, Germany· Est.
aska-biotech.de
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

ASKA Biotech is an established, privately-held German CDMO providing non-GMP bioprocessing services with a core focus on the diagnostics and research supply markets. Its service portfolio includes custom antibody manufacturing (monoclonal and recombinant), recombinant protein expression in CHO, HEK, and E. coli systems, cell line development, and diagnostic assay development (ELISA, LIA, LFA). The company differentiates itself through its ISO 13485 quality management system, IVDR compliance, 'Made in Germany' positioning, and a customer-centric approach that includes custom workflows and digital tools like an AI-powered virtual assistant.

AntibodiesBiologics

Technology Platform

Suite of ISO 13485-certified processes for recombinant protein and antibody production in CHO, HEK, and E. coli expression systems. Services include custom cell line development (stable transfection), rapid transient expression, monoclonal and recombinant antibody production, and diagnostic immunoassay development (ELISA, LIA, LFA).

Funding History

1
SeedUndisclosed

Opportunities

The enforcement of the EU's In Vitro Diagnostic Regulation (IVDR) creates strong demand for ISO 13485-certified partners to supply compliant raw materials.
The growing point-of-care testing (POCT) and decentralized diagnostics market presents a key growth area for custom assay and component development.
Digital tools like its AI virtual assistant (AVA) can enhance customer service efficiency and differentiation.

Risk Factors

Revenue is project-dependent and susceptible to client budget cycles and concentration risk.
Intense competition in the CDMO market from larger global players and niche specialists pressures pricing and service differentiation.
Maintaining ISO 13485 certification and IVDR compliance requires continuous investment and exposes the company to regulatory audit risks.

Competitive Landscape

ASKA Biotech competes in the fragmented global biologics CDMO and IVD raw materials market. Key competitors range from large, full-service CDMOs (e.g., Lonza, Sartorius) to smaller, specialized antibody/protein service providers. Its primary differentiation is its focused ISO 13485 certification for IVDR compliance, 'Made in Germany' quality positioning, and flexibility in serving non-GMP diagnostic and research clients.

More companies in Biologics / Biosimilars →More companies in Germany →